IND Opens for Anti-Staphylococcal Drug XF-73 and NIAID-Funded US Clinical Trial Begins

BRIGHTON, UNITED KINGDOM -- (Marketwire) -- 03/26/12 -- Clinical stage pharmaceutical company Destiny Pharma today made…

Continue Reading